30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Akoya Biosciences Inc (AKYA)

Track

Stock chart
Ticker: AKYA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
McKelligon Brian
President and CEO
1 sale — total 15,630 USD
Planned sale 11 Jun 2024
Value US$3,223,082.00 | Price 388.72 | Shares 12,403
Proposed sale 11 Jun 2024
Value US$212,562.15 | Price 495.06 | Shares 3,097
Planned sale 6 Jun 2024
Value US$15,063.75 | Price 2.01 | Shares 7,500
Proposed sale 6 Jun 2024
Value US$15,063.75 | Price 2.01 | Shares 7,500
Planned sale 20 Mar 2024
Value US$37,242.75 | Price 4.97 | Shares 7,500
Proposed sale 20 Mar 2024
Value US$37,242.75 | Price 4.97 | Shares 7,500
Planned sale 13 Mar 2024
Value US$37,035.00 | Price 4.94 | Shares 7,500
Proposed sale 13 Mar 2024
Value US$37,041.00 | Price 4.94 | Shares 7,500
Planned sale 19 Dec 2023
Value US$33,565.50 | Price 4.48 | Shares 7,500
Proposed sale 19 Dec 2023
Value US$33,565.50 | Price 4.48 | Shares 7,500
Planned sale 12 Dec 2023
Value US$31,871.25 | Price 4.25 | Shares 7,500
Proposed sale 12 Dec 2023
Value US$31,871.25 | Price 4.25 | Shares 7,500
Planned sale 20 Nov 2023
Value US$32,901.00 | Price 4.39 | Shares 7,500
Proposed sale 20 Nov 2023
Value US$32,901.00 | Price 4.39 | Shares 7,500
Buy 7 Sep 2023
Value US$32,200.00 | Price 4.60 | Shares 7,000
Buy 7 Sep 2023
Value US$59,814.30 | Price 4.60 | Shares 13,000
Proposed sale 13 Jul 2023
Value US$71,750.00 | Price 7.18 | Shares 10,000
Proposed sale 12 Jul 2023
Value US$388,977.00 | Price 20.97 | Shares 18,553
Proposed sale 15 Jun 2023
Value US$160,000.00 | Price 8.00 | Shares 20,000
Proposed sale 14 Jun 2023
Value US$178,773.36 | Price 7.79 | Shares 22,962
Proposed sale 13 Jun 2023
Value US$64,571.19 | Price 6.46 | Shares 10,000
Buy 12 Jun 2023
Value US$600,000.00 | Price 5.00 | Shares 120,000
Buy 12 Jun 2023
Value US$100,000.00 | Price 5.00 | Shares 20,000
Buy 12 Jun 2023
Value US$1,016,940.00 | Price 5.00 | Shares 203,388
Buy 12 Jun 2023
Value US$100,000.00 | Price 5.00 | Shares 20,000
Buy 12 Jun 2023
Value US$9,016,865.00 | Price 5.00 | Shares 1,803,373
Buy 12 Jun 2023
Value US$983,135.00 | Price 5.00 | Shares 196,627
Buy 12 Jun 2023
Value US$100,000.00 | Price 5.00 | Shares 20,000
Buy 12 Jun 2023
Value US$100,000.00 | Price 5.00 | Shares 20,000
Proposed sale 6 Jun 2023
Value US$55,500.00 | Price 5.55 | Shares 10,000
Proposed sale 6 Jun 2023
Value US$28,537.00 | Price 5.71 | Shares 5,000
Planned sale 6 Jun 2023
Value US$28,537.00 | Price 5.71 | Shares 5,000
Proposed sale 31 May 2023
Value US$57,500.00 | Price 5.75 | Shares 10,000
Proposed sale 24 May 2023
Value US$90,750.00 | Price 6.05 | Shares 15,000
Proposed sale 17 May 2023
Value US$59,500.00 | Price 5.95 | Shares 10,000
Planned sale 14 Mar 2023
Value US$2,241.47 | Price 9.92 | Shares 226
Planned sale 14 Mar 2023
Value US$43,610.49 | Price 9.14 | Shares 4,774
Sale 14 Dec 2022
Value US$181,519.17 | Price 12.46 | Shares 14,574
Sale 14 Dec 2022
Value US$127,187.10 | Price 12.67 | Shares 10,039
Sale 13 Dec 2022
Value US$925,781.50 | Price 13.03 | Shares 71,050
Planned sale 6 Dec 2022
Value US$60,415.00 | Price 12.08 | Shares 5,000
Sale 2 Dec 2022
Value US$14,575.00 | Price 13.25 | Shares 1,100
Sale 1 Dec 2022
Value US$66,788.00 | Price 13.36 | Shares 5,000
Sale 16 Nov 2022
Value US$3,975.99 | Price 13.25 | Shares 300
Sale 14 Nov 2022
Value US$7,966.02 | Price 13.28 | Shares 600
Sale 11 Nov 2022
Value US$265,858.00 | Price 13.29 | Shares 20,000
Sale 10 Nov 2022
Value US$50,705.38 | Price 13.31 | Shares 3,810
Sale 14 Sep 2022
Value US$110,084.44 | Price 13.26 | Shares 8,305
Sale 12 Sep 2022
Value US$23,944.14 | Price 13.30 | Shares 1,800
Sale 9 Sep 2022
Value US$295,337.80 | Price 13.31 | Shares 22,191
Planned sale 7 Sep 2022
Value US$64,170.00 | Price 12.83 | Shares 5,000
Sale 15 Jun 2022
Value US$51,260.00 | Price 10.25 | Shares 5,000
Sale 13 Dec 2021
Value US$1,325.00 | Price 13.25 | Shares 100
Sale 9 Dec 2021
Value US$316,762.50 | Price 12.67 | Shares 25,000
Buy 22 Nov 2021
Value US$328,292.50 | Price 13.13 | Shares 25,000
Buy 19 Nov 2021
Value US$938.05 | Price 12.85 | Shares 73
Buy 19 Nov 2021
Value US$111,860.00 | Price 13.16 | Shares 8,500
Buy 18 Nov 2021
Value US$258,500.00 | Price 12.93 | Shares 20,000
Buy 18 Nov 2021
Value US$182,505.00 | Price 12.17 | Shares 15,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-12 2024-06-11 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
12,403 +47.0%
388.72
US$3,223,082 		12,403 +47.0% 388.72 US$3,223,082
2024-06-11 2024-06-11 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
3,097
495.06
US$212,562 		3,097 495.06 US$212,562
2024-06-07 2024-06-06 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
97,613 +3.5%
477.88
US$4,147,910 		97,613 +3.5% 477.88 US$4,147,910
2024-06-06 2024-06-06 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
2.01
US$15,064 		7,500 2.01 US$15,064
2024-03-22 2024-03-20 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -3.1%
4.97
US$37,243 		7,500 -3.1% 4.97 US$37,243
2024-03-20 2024-03-20 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.97
US$37,243 		7,500 4.97 US$37,243
2024-03-14 2024-03-13 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -3.2%
4.94
US$37,035 		7,500 -3.2% 4.94 US$37,035
2024-03-13 2024-03-13 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.94
US$37,041 		7,500 4.94 US$37,041
2023-12-20 2023-12-19 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -4.7%
4.48
US$33,566 		7,500 -4.7% 4.48 US$33,566
2023-12-19 2023-12-19 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.48
US$33,566 		7,500 4.48 US$33,566
2023-12-14 2023-12-12 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -4.7%
4.25
US$31,871 		7,500 -4.7% 4.25 US$31,871
2023-12-12 2023-12-12 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.25
US$31,871 		7,500 4.25 US$31,871
2023-11-22 2023-11-20 PlS Planned sale
0.6
McKelligon Brian

President and CEO

Executive Director
7,500 -4.7%
4.39
US$32,901 		7,500 -4.7% 4.39 US$32,901
2023-11-20 2023-11-20 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
7,500
4.39
US$32,901 		7,500 4.39 US$32,901
2023-09-11 2023-09-07 B Purchase
0.8
Pla Frederic

Chief Operating Officer

Officer
7,000 +53.8%
4.60
US$32,200 		7,000 +53.8% 4.60 US$32,200
2023-09-11 2023-09-07 B Purchase
0.8
Pla Frederic

Chief Operating Officer

Officer
13,000 +inf%
4.60
US$59,814 		13,000 +inf% 4.60 US$59,814
2023-07-13 2023-07-13 PrS Proposed sale
Moy Marilee

Officer

Officer
10,000
7.18
US$71,750 		10,000 7.18 US$71,750
2023-07-12 2023-07-12 PrS Proposed sale
Moy Marilee

Officer

Officer
18,553
20.97
US$388,977 		18,553 20.97 US$388,977
2023-06-15 2023-06-15 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
20,000
8.00
US$160,000 		20,000 8.00 US$160,000
2023-06-14 2023-06-14 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
22,962
7.79
US$178,773 		22,962 7.79 US$178,773
2023-06-13 2023-06-13 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
6.46
US$64,571 		10,000 6.46 US$64,571
2023-06-12 2023-06-12 B Purchase
2.5
SHEPLER ROBERT G
Non-Executive Director
120,000 +48.1%
5.00
US$600,000 		120,000 +48.1% 5.00 US$600,000
2023-06-12 2023-06-12 B Purchase
1.6
Ek John Frederick

CFO

Officer
20,000 +inf%
5.00
US$100,000 		20,000 +inf% 5.00 US$100,000
2023-06-12 2023-06-12 B Purchase
1.6
Winkler Matthew
Non-Executive Director
203,388 +26.0%
5.00
US$1,016,940 		203,388 +26.0% 5.00 US$1,016,940
2023-06-12 2023-06-12 B Purchase
1.6
LAI GOLDMAN MYLA
Non-Executive Director
20,000 +inf%
5.00
US$100,000 		20,000 +inf% 5.00 US$100,000
2023-06-12 2023-06-12 B Purchase
2.1
Raffin Thomas A.
Non-Executive Director
1,803,373 +12.8%
5.00
US$9,016,865 		1,803,373 +12.8% 5.00 US$9,016,865
2023-06-12 2023-06-12 B Purchase
2.1
Raffin Thomas A.
Non-Executive Director
196,627 +12.8%
5.00
US$983,135 		196,627 +12.8% 5.00 US$983,135
2023-06-12 2023-06-12 B Purchase
2.1
Raffin Thomas A.
Non-Executive Director
20,000 +9.3%
5.00
US$100,000 		20,000 +9.3% 5.00 US$100,000
2023-06-12 2023-06-12 B Purchase
2.2
Mendel Scott
Non-Executive Director
20,000 +235.3%
5.00
US$100,000 		20,000 +235.3% 5.00 US$100,000
2023-06-06 2023-06-06 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
5.55
US$55,500 		10,000 5.55 US$55,500
2023-06-06 2023-06-06 PrS Proposed sale
0.6
BRIAN M MCKELLIGON

Officer; Director

Executive Director
5,000
5.71
US$28,537 		5,000 5.71 US$28,537
2023-06-06 2023-06-06 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Executive Director
5,000 -3.2%
5.71
US$28,537 		5,000 -3.2% 5.71 US$28,537
2023-05-31 2023-05-31 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
5.75
US$57,500 		10,000 5.75 US$57,500
2023-05-24 2023-05-24 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
15,000
6.05
US$90,750 		15,000 6.05 US$90,750
2023-05-17 2023-05-17 PrS Proposed sale
3.2
DRISCOLL JOSEPH

Officer

Officer
10,000
5.95
US$59,500 		10,000 5.95 US$59,500
2023-03-16 2023-03-14 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Executive Director
226 -0.1%
9.92
US$2,241 		226 -0.1% 9.92 US$2,241
2023-03-16 2023-03-14 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Executive Director
4,774 -2.9%
9.14
US$43,610 		4,774 -2.9% 9.14 US$43,610
2022-12-16 2022-12-14 S Sale
3.2
DRISCOLL JOSEPH

Chief Financial Officer

Officer
14,574 -53.8%
12.46
US$181,519 		14,574 -53.8% 12.46 US$181,519
2022-12-16 2022-12-14 S Sale
3.2
DRISCOLL JOSEPH

Chief Financial Officer

Officer
10,039 -44.5%
12.67
US$127,187 		10,039 -44.5% 12.67 US$127,187
2022-12-20 2022-12-13 S Sale
3.7
SCHNETTLER THOMAS P
Non-Executive Director
71,050 -2.5%
13.03
US$925,782 		71,050 -2.5% 13.03 US$925,782
2022-12-08 2022-12-06 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Officer
5,000 -5.9%
12.08
US$60,415 		5,000 -5.9% 12.08 US$60,415
2022-12-06 2022-12-02 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
1,100 -0.2%
13.25
US$14,575 		1,100 -0.2% 13.25 US$14,575
2022-12-02 2022-12-01 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
5,000 -0.8%
13.36
US$66,788 		5,000 -0.8% 13.36 US$66,788
2022-11-17 2022-11-16 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
300 -0.1%
13.25
US$3,976 		300 -0.1% 13.25 US$3,976
2022-11-14 2022-11-14 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
600 -0.1%
13.28
US$7,966 		600 -0.1% 13.28 US$7,966
2022-11-14 2022-11-11 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
20,000 -3.2%
13.29
US$265,858 		20,000 -3.2% 13.29 US$265,858
2022-11-14 2022-11-10 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
3,810 -0.6%
13.31
US$50,705 		3,810 -0.6% 13.31 US$50,705
2022-09-16 2022-09-14 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
8,305 -1.3%
13.26
US$110,084 		8,305 -1.3% 13.26 US$110,084
2022-09-13 2022-09-12 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
1,800 -0.3%
13.30
US$23,944 		1,800 -0.3% 13.30 US$23,944
2022-09-13 2022-09-09 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
22,191 -3.4%
13.31
US$295,338 		22,191 -3.4% 13.31 US$295,338
2022-09-09 2022-09-07 PlS Planned sale
0.6
McKelligon Brian

President/CEO

Officer
5,000 -5.9%
12.83
US$64,170 		5,000 -5.9% 12.83 US$64,170
2022-06-17 2022-06-15 S Sale
0.6
McKelligon Brian

President/CEO

Officer
5,000 -5.9%
10.25
US$51,260 		5,000 -5.9% 10.25 US$51,260
2022-12-15 2021-12-13 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
100 -0.0%
13.25
US$1,325 		100 -0.0% 13.25 US$1,325
2021-12-13 2021-12-09 S Sale
3.8
Nolan Garry Ph.D.
Non-Executive Director
25,000 -3.7%
12.67
US$316,762 		25,000 -3.7% 12.67 US$316,762
2021-11-22 2021-11-22 B Purchase
1.8
Ramachandran Niro Ph.D

Chief Business Officer

Officer
25,000 +34246.6%
13.13
US$328,292 		25,000 +34246.6% 13.13 US$328,292
2021-11-22 2021-11-19 B Purchase
1.8
Ramachandran Niro Ph.D

Chief Business Officer

Officer
73 +inf%
12.85
US$938 		73 +inf% 12.85 US$938
2021-11-19 2021-11-19 B Purchase
2.2
Mendel Scott
Non-Executive Director
8,500 +inf%
13.16
US$111,860 		8,500 +inf% 13.16 US$111,860
2021-11-18 2021-11-18 B Purchase
2.5
SHEPLER ROBERT G
Non-Executive Director
20,000 +133.3%
12.93
US$258,500 		20,000 +133.3% 12.93 US$258,500
2021-11-18 2021-11-18 B Purchase
2.5
SHEPLER ROBERT G
Non-Executive Director
15,000 +inf%
12.17
US$182,505 		15,000 +inf% 12.17 US$182,505
Explore more

More insider trading research around Akoya Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America